JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Issues journals
Medical Radiology and Radiation Safety. 2025. Vol. 70. № 2
DOI:10.33266/1024-6177-2025-70-2-9-15
P.A. Malakhov1, M.V. Pustovalova1, A.V. Aleksandrova1, E.G. Kontareva1,
A.V. Smirnova1, Z. Nofal1, A.N. Osipov1, 2, S.V. Leonov1
Repetitive Confined Migration Leads to an Increase in Clonogenic Activity and Chemoresistanse of Human Non-Small Cell Lung Cancer Cells, Regardless of Their Initial Chemo- and Radiosensitivity
1 Moscow Institute of Physics and Technology (National Research University), Dolgoprudny, Russia
2 A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
Contact person: M.V. Pustovalova, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: Radiation therapy can treat non-small cell lung cancer (NSCLC), but its effectiveness is limited by the development of tumor radioresistance. Studies have shown that radiation can affect tumor aggressiveness, either reducing or increasing the invasiveness of remaining cancer cells, depending on the cell lines and radiation type. However, the effect of tumor cell migration in the confined porous space of tumor tissue on their phenotypic characteristics is not well understood. This study aimed to investigate how migration in confined spaces affects the phenotypic traits of two NSCLC isogenic cell lines with varying levels of radioresistance, invasiveness, and repopulation ability.
Material and methods: The biophysical impact on the A549 cell line and its isogenic radioresistant subline A549IR was carried out by their sequential triple migration in a limited space of membrane pores with a diameter of 8 μm in Boyden chambers, following the concentration gradient of fetal bovine serum. The ability to repopulate cell populations migrated across membranes was characterized using clonogenic analysis. We assessed markers such as Ki67 (cell cycle activity), vimentin (a cytoskeletal protein linked to migration and metastasis), and fluorescent nanosensor uptake (indicating metastasis potential) through quantitative analysis of digital images from high-content imaging of individual cells. A standard method for determining cell mass with the dye sulphorodamine B after exposure to different concentrations of cisplatin was used to assess the chemosensitivity of tumor cells before and after migration.
Results and Conclusion: The study shows that repeated migration through an 8 μm pore, which simulates conditions cancer cells experience during metastasis, deforms the nuclei of non-small cell lung cancer (NSCLC) cells. This deformation reduces Ki67-related chromatin reorganization and alters gene expression, notably increasing vimentin. This results in increased chemoresistance and a greater likelihood of repopulation and metastasis in these cells, regardless of their initial ability to migrate or their sensitivity to chemotherapy and radiation.
Keywords: non-small cell lung cancer, radioresistance, chemoresistance, confined migration, metastatic activity, endocytosis, nanosensors
For citation: Malakhov PA, Pustovalova MV, Aleksandrova AV, Kontareva EG, Smirnova AV, Nofal Z, Osipov AN, Leonov SV. Repetitive Confined Migration Leads to an Increase in Clonogenic Activity and Chemoresistanse of Human Non-Small Cell Lung Cancer Cells, Regardless of Their Initial Chemo- and Radiosensitivity. Medical Radiology and Radiation Safety. 2025;70(2):9–15. (In Russian). DOI:10.33266/1024-6177-2025-70-2-9-15
References
1. Aupérin A., Le Péchoux C., Rolland E., et al. Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer. J Clin On col. 2010;28;13:2181-2190. doi: 10.1200/JCO.2009.26.2543. PMID: 20351327.
2. Friedl P., Wolf K. Tumour-Cell Invasion and Migration: Diversity and Escape Mechanisms. Nat Rev Cancer. 2003;3;5:362 374. doi:10.1038/nrc1075. PMID: 12724734.
3. Fanfone D., Wu Z., Mammi J., et al. Confined Migration Promotes Cancer Metastasis Through Resistance to Anoikis and Increased Invasiveness. Elife. 2022;11:e73150. doi:10.7554/ eLife.73150. PMID: 35256052.
4. Fujita, M., Yamada, S., & Imai, T. (2015). Irradiation induces diverse changes in invasive potential in cancer cell lines. Seminars in cancer biology, 35, 45–52. https:// doi.org/10.1016/j.semcancer.2015.09.003
5. Shieh A.C. Biomechanical Forces Shape the Tumor Microenvironment. Ann Biomed Eng. 2011;39;5:1379-1389. doi:10.1007/ s10439-011-0252-2. PMID: 21253819.
6. Pustovalova M., Alhaddad L., Smetanina N., et al. The p53 53BP1-Related Survival of A549 and H1299 Human Lung Cancer Cells after Multifractionated Radiotherapy Demonstrated Different Response to Additional Acute X-ray Exposure. Int J Mol Sci. 2020;21;9:3342. doi:10.3390/ijms21093342. PMID: 32397297.
7. Merkher Y., Kontareva E., Bogdan E., et al. Encapsulation and Adhesion of Nanoparticles as a Potential Biomarker for TNBC Cells Metastatic Propensity. Sci Rep. 2023;13;1:12289. doi:10.1038/s41598-023-33540-1. PMID: 37516753.
8. Wang M., Yi J., Gao H., et al. Radiation-Induced YAP/TEAD4 Binding Confers Non-Small Cell Lung Cancer Radioresistance Via Promoting NRP1 Transcription. Cell Death Dis. 2024;15;8:619. doi:10.1038/s41419-024-07017-6. PMID: 39187525.
9. Alhaddad L., Pustovalova M., Blokhina T., Chuprov-Netochin R., Osipov A.N., Leonov S. IR-Surviving NSCLC Cells Exhibit Different Patterns of Molecular and Cellular Reactions Relating to the Multifraction Irradiation Regimen and p53-Family Proteins Expression. Cancers (Basel). 2021;13;11:2669. doi:10.3390/cancers13112669. PMID: 34071477.
10. Gan, Z., Ding, L., Burckhardt, C. J., Lowery, J., Zaritsky, A., Sitterley, K., Mota, A., Costigliola, N., Starker, C.G., Voytas, D.F., Tytell, J., Goldman, R.D., & Danuser, G. (2016). Vimentin Intermediate Filaments Template Microtubule Networks to Enhance Persistence in Cell Polarity and Directed Migration. Cell systems, 3(3), 252–263.e8.
11. Mendez, M. G., Restle, D., & Janmey, P. A. (2014). Vimentin enhances cell elastic behavior and protects against compressive stress. Biophysical journal, 107(2), 314–323. https://doi. org/10.1016/j.bpj.2014.04.050/
12. Hu, J., Li, Y., Hao, Y., Zheng, T., Gupta, S. K., Parada, G. A., Wu, H., Lin, S., Wang, S., Zhao, X., Goldman, R. D., Cai, S., & Guo, M. (2019). High stretchability, strength, and toughness of living cells enabled by hyperelastic vimentin intermediate filaments. Proceedings of the National Academy of Sciences of the United States of America, 116(35), 17175–17180. https:// doi.org/10.1073/pnas.1903890116.
13. Xuan, B., Ghosh, D., Cheney, E. M., Clifton, E. M., & Dawson, M. R. (2018). Dysregulation in Actin Cytoskeletal Organization Drives Increased Stiffness and Migratory Persistence in Polyploidal Giant Cancer Cells. Scientific reports, 8(1), 11935. https://doi.org/10.1038/s41598-018-29817-5.
14. Esue O., Carson A.A., Tseng Y., Wirtz D. A Direct Interaction between Actin and Vimentin Filaments Mediated by the Tail Domain of Vimentin. J Biol Chem. 2006;281;41:30393-30399. doi:10.1074/jbc.M605452200. PMID: 16901892.
15. Shen Q, Hill T, Cai X, Bui L, Barakat R, Hills E, Almugaiteeb T, Babu A, Mckernan PH, Zalles M, Battiste JD, Kim YT. Physical confinement during cancer stem cell-like behavior. Cancer Lett. 2021 May 28;506:142-151. doi: 10.1016/j.canlet.2021.01.020
16. Bunn P.A. Jr. The Expanding Role of Cisplatin in the Treatment of Non-Small-Cell Lung Cancer. Semin Oncol. 1989;16;4;6:10 21. PMID: 2548280.
17. Cho K., Choi E.S., Kim J.H., Son J.W., Kim E. Numerical Learning of Deep Features from Drug-Exposed Cell Images to Calculate IC50 without Staining. Sci Rep. 2022;12;1:6610. Published 2022 Apr 22. doi:10.1038/s41598-022-10643-9. PMID: 35459284.
18. Xuan, B., Ghosh, D., Jiang, J., Shao, R., & Dawson, 19. M.R. (2020). Vimentin filaments drive migratory persistence in polyploidal cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 117(43), 26756–26765. https://doi. org/10.1073/pnas.2011912117
19. Valeriote, F. and L. van Putten, Proliferation-dependent cytotoxicity of anticancer agents: a review. Cancer research, 1975. 35(10): p. 2619-2630;
20. Stover, D.G., et al, The Role of Proliferation in Determining Response to Neoadjuvant Chemotherapy in Breast Cancer: A Gene Expression–Based Meta-Analysis. Clinical Cancer Research, 2016. 22(24): p. 6039-6050.
21. Tubiana, M. et al, The long-term prognostic significance of the thymidine labelling index in breast cancer. International journal of cancer, 1984. 33(4): p. 441−445
22. Miller, I. et al, Ki67 is a graded rather than a binary marker of proliferation versus quiescence. Cell reports, 2018. 24(5): p. 1105−1112. e5
23. Sobecki, M., et al, The cell proliferation antigen Ki-67 organises heterochromatin. elife, 2016. 5: p. e13722;
24. Mrouj, K., et al, Ki 67 regulates global gene expression and promotes sequential stages of carcinogenesis. Proceedings of the National Academy of Sciences, 2021. 118(10): p. e2026507118.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The work was supported by the Ministry of Science and Higher Education of the Russian Federation (State Assignment): “Development of local drug delivery systems for medical purposes”, number FSMG-2023-0015, agreement number No. 075-03-2024-117 dated 17.01.2024.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.12.2024. Accepted for publication: 25.01.2025.
Medical Radiology and Radiation Safety. 2025. Vol. 70. № 2
DOI:10.33266/1024-6177-2025-70-2-16-22
S.A. Abdullaev1, 2, 3, D.V. Fomina1, 3, V.O. Menukhov1, 2, M.V. Dushenko1,
A.V. Tochilenko4, T.P. Kalinin5, E.V. Evdokimovskii2
Changes in the Copy Number and Gene Expression of mtDNA
in Various Tissues of Mice Exposed to Local Brain Irradiation
1 N.N. Semenov Federal Research Center for Chemical Physics, Moscow, Russia
2 Institute of Theoretical and Experimental Biophysics, Pushchino, Russia
3 A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
4 National Research Nuclear University MEPhI, Moscow, Russia
5 N.I. Pirogov Russian National Research Medical University, Moscow, Russia
Contact person: S.A. Abdullaev, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: To determine changes in the copy number and gene expression of mtDNA in various tissues of mice subjected to local irradiation of the brain.
Material and methods: Male Balb/c mice aged 2 months were used. Only the head of the mouse was exposed to X-ray irradiation at a dose of 5 Gy (power 2.5 Gy/min). After removal from the animals, the tissues were homogenized on ice, after which the homogenate mass was divided into two parts to isolate nucleic acids. Liquid blood was collected separately, after which nucleated blood cells were separated into granulocyte and monocyte fractions by differential centrifugation by Diacoll density gradient. The total number of mtDNA copies and gene expression were assessed using real-time PCR.
Results: It was shown that in nucleated blood cells, after irradiation, the relative number of transcripts of the mitochondrial gene ATP6 increases. In granulocytes, this effect is much more pronounced than in monocytes. At the same time, the amount of mitochondrial DNA in nucleated blood cells decreases relative to the control level by 2–3 times. In the brain exposed to irradiation, an increase in the relative amount of mtDNA transcripts by about 3 times is also observed, compared to the control. In organs not exposed to irradiation (heart, liver, spleen), the same effect is observed as in the brain, namely, an increase in the relative amount of mtDNA transcripts. The number of copies of mtDNA itself in brain cells, after a sharp increase a day after irradiation, sharply decreases and remains so until the end of the experiment, 30 days later. In liver and heart cells, the opposite process occurs, namely, a significant increase in the number of mtDNA copies, with a maximum at 14–21 days from the moment of irradiation.
Conclusion: Thus, the obtained results allow us to say that the observed changes are due to the occurrence of the “bystander effect” that arose after local irradiation of the brain with X-ray radiation at a dose of 5 Gy.
Keywords: mtDNA, bystander effect, oxidative stress, X-ray exposure, brain, mice
For citation: Abdullaev SA, Fomina DV, Menukhov VO, Dushenko MV, Tochilenko AV, Kalinin TP, Evdokimovskii EV. Changes in the Copy Number and Gene Expression of mtdna in Various Tissues of Mice Exposed to Local Brain Irradiation. Medical Radiology and Radiation Safety. 2025;70(2):16–22. (In Russian). DOI:10.33266/1024-6177-2025-70-2-16-22
References
1. Pant G.S., Kamada N. Chromosome Aberrations in Normal Leukocytes Induced by the Plasma of Exposed Individuals. J Med Sci. 1977;26;2-3:149-154.
2. Hollowell J.G., Littlefeld L.G. Chromosome Damage Induced by Plasma of X-Rayed Patients: an Indirect Effect of X-Ray. Proc Soc Exp Biol Med. 1968;129;1:240-244. doi: 10.3181/00379727-129-33295.
3. Littlefeld L.G., Hollowell Jr J.G., Pool Jr W.H. Chromosomal Aberrations Induced by Plasma from Irradiated Patients: an Indirect Effect of X Radiation. Further Observations and Studies of a Control Population. Radiology. 1969;93;4:879-886. doi: 10.1148/93.4.879.
4. Marozik P., Mothersill C., Seymour C.B., Mosse I., Melnov S. Bystander Effects Induced by Serum from Survivors of the Chernobyl Accident. Exp Hematol. 2007;35;4-1:55-63. doi: 10.1016/j.exphem.2007.01.029.
5 Emerit I., Quastel M., Goldsmith J., Merkin L., Levy A., Cernjavski L., et al. Clastogenic Factors in the Plasma of Children Exposed at Chernobyl. Mutat Res. 1997;373;1:47-54. doi: 10.1016/s0027-5107(96)00187-x.
6. Gemignani F., Ballardin M., Maggiani F., Rossi A.M., Antonelli A., Barale R. Chromosome Aberrations in Lymphocytes and Clastogenic Factors in Plasma Detected in Belarus Children 10 Years after Chernobyl Accident. Mutat Res. 1999;446;2:245-253. doi: 10.1016/s1383-5718(99)00194-1.
7. Nagasawa H., Little J.B. Induction of Sister Chromatid Exchanges by Extremely Low Doses of Alpha-Particles. Cancer Res. 1992;52;22:6394-6.
8. Ghosh G. Radiation-Induced Bystander Effect and Its Possible Countermeasures. J Cell Signal. 2023;4;1:13-20. doi: 10.33696/Signaling.4.086.
9. Gilbert A., Payet V., Bernay B., Chartier-Garcia E., Testard I., Candéias S.M., Chevalier F. Label-Free Direct Mass Spectrometry Analysis of the Bystander Effects Induced in Chondrocytes by Chondrosarcoma Cells Irradiated with X-rays and Carbon Ions. Front Biosci (Landmark Ed). 2022;27;9:277. doi: 10.31083/j.fbl2709277.
10. Vasilyeva I.N. Low-Molecular-Weight DNA in Blood Plasma as an Index of the Influence of Ionizing Radiation. Ann N Y Acad Sci. 2001;945:221-8. doi: 10.1111/j.1749-6632.2001.tb03889.x.
11. Cooke M.S., Evans M.D., Dizdaroglu M., Lunec J. Oxidative DNA Damage: Mechanisms, Mutation, and Disease. FASEB J. 2003;17;10:1195-1214. doi: 10.1096/fj.02-0752rev.
12. Ermakov A.V., Konkova M.S., Kostyuk S.V., Smirnova T.D., Malinovskaya E.M., Efremova L.V., Veiko N.N. An Extracellular DNA Mediated Bystander Effect Produced from Low Dose Irradiated Endothelial Cells. Mutat Res. 2011;712;1-2:1-10. doi: 10.1016/j.mrfmmm.2011.03.002.
13. Randhawa A.K., Hawn T.R. Toll-Like Receptors: their Roles in Bacterial Recognition and Respiratory Infections. Expert Rev Anti Infect Ther. 2008;6;4:479-495. doi: 10.1586/14787210.6.4.479.
14. Taanman J.W. The Mitochondrial Genome: Structure, Transcription, Translation and Replication. Biochim Biophys Acta. 1999;1410;2:103-123. doi: 10.1016/s0005-2728(98)00161-3.
15. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., et al. Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury. Nature. 2010;464;7285:104-107. doi: 10.1038/nature08780.
16. Liu Q., Wu J., Zhang X., Li X., Wu X., Zhao Y., Ren J. Circulating Mitochondrial DNA-Triggered Autophagy Dysfunction Via STING Underlies Sepsis-Related Acute Lung Injury. Cell Death Dis. 2021;12;7:673. doi: 10.1038/s41419-021-03961-9.
17. Mothersill C., Seymour C. Radiation-Induced Bystander Effects: Past History and Future Directions. Radiat Res. 2001;155;6:759-67. doi: 10.1667/0033-7587(2001)155[0759:ribeph]2.0.co;2.
18. Nikjoo H., Khvostunov I.K. Biophysical Model of the Radiation-Induced Bystander Effect. Int J Radiat Biol. 2003;79;1:43-52.
19. Nikjoo H., Khvostunov I.K. A Theoretical Approach to the Role and Critical Issues Associated with Bystander Effect in Risk Estimation. Hum Exp Toxicol. 2004;23;2:81-6. doi: 10.1191/0960327104ht422oa.
20. Azzam E.I., De Toledo S.M., Spitz D.R., Little J.B. Oxidative Metabolism Modulates Signal Transduction and Micronucleus Formation in Bystander Cells from Alpha-Particle-Irradiated Normal Human Fibroblast Cultures. Cancer Res. 2002;62;19:5436-42.
21. Matsumoto H., Hamada N., Takahashi A., Kobayashi Y., Ohnishi T. Vanguards of Paradigm Shift in Radiation Biology: Radiation-Induced Adaptive and Bystander Responses. J Radiat Res. 2007;48;2:97-106. doi: 10.1269/jrr.06090.
22. Matsumoto H., Tomita M., Otsuka K., Hatashita M., Hamada N. Nitric Oxide is a Key Molecule Serving as a Bridge between Radiation-Induced Bystander and Adaptive Responses. Curr Mol Pharmacol. 2011;4;2:126-34. doi: 10.2174/1874467211104020126.
23. Morgan W.F. Communicating Non-Targeted Effects of Ionizing Radiation to Achieve Adaptive Homeostasis in Tissues. Curr Mol Pharmacol. 2011;4;2:135-40.
24. Ermakov A.V., Kon’kova M.S., Kostyuk S.V., Ershova E.S., Egolina N.A., Veĭko N.N. Extracellular DNA Fragments from Culture Medium of Low-Dose Irradiated Human Lymphocyte Trigger Instigating of the Oxidative Stress and the Adaptive Response in Non-Irradiated Bystander Lymphocytes. Radiats Biol Radioecol. 2008;48;5:553-64.
25. Kostyuk S.V., Ermakov A.V., Alekseeva A.Yu., Smirnova T.D., Glebova K.V., Efremova L.V., Baranova A., Veiko N.N. Role of Extracellular DNA Oxidative Modification in Radiation Induced Bystander Effects in Human Endotheliocytes. Mutat Res. 2012;729;1-2:52-60. doi: 10.1016/j.mrfmmm.2011.09.005.
26. Wu Z., Oeck S., West A.P., Mangalhara K.C., Sainz A.G., Newman L.E., et al. Mitochondrial DNA Stress Signalling Protects the Nuclear Genome. Nat Metab. 2019;1;12:1209-1218. doi: 10.1038/s42255-019-0150-8.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The work was supported by the Russian Science Foundation (project No. 24-24-00446).
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.12.2024. Accepted for publication: 25.01.2025.
Medical Radiology and Radiation Safety. 2025. Vol. 70. № 2
DOI:10.33266/1024-6177-2025-70-2-27-34
P.A. Malakhov1, V.V. Maximov2, M.V. Pustovalova1, A.V. Smirnova1, Z. Nofal1,
V. Saburov3, A.N. Osipov1, D.V. Kuzmin1, S.V. Leonov1, 4
MiR-16-1-3p and miR-16-2-3p Overexpression Confers Tumor Suppressive and Antimetastatic Properties in Radioresistant A549 Non-Small Cell Lung Cancer Cells
1 Institute of Future Biophysics, Dolgoprudny, Russia
2 Department of Molecular Genetics and Microbiology, Institute of Medical Research, Israel–Canada,
Faculty of Medicine, Hebrew University, Jerusalem, Israel
3 A.F. Tsyb Medical Research Center of Radiology, Obninsk, Russia
4 Pushchino Scientific Center for Biological Research Institute of Cell Biophysics, Pushchino, Russia
Contact person: M.V. Pustovalova, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: Lung cancer is the leading cause of death worldwide, with non-small cell lung cancer (NSCLC) accounting for 85 % of all lung cancers. Combined chemoradiotherapy is one of options in the treatment of patients with inoperable NSCLC. However, the prognosis of NSCLC remains unsatisfactory due to the development of radio- and chemo-resistance of cancer cells. This study aimed to investigate how the overexpression of miR-16, miR-16-1-3p, and miR-16-2-3p influences clonogenic survival, migration, and sensitivity to cisplatin in both radiosensitive and radioresistant non-small cell lung cancer (NSCLC) cells.
Material and methods: This study involved the application of single proton beam irradiation to A549 NSCLC cells, resulting in the emergence of a subline of resilient radioresistant daughter cells, designated as A549IR. To explore the functional role of the miR-16, miR-16-1-3p, and miR-16-2-3p in NSCLC, we overexpressed the “leader” miR-16 as well as the “passenger” miR-16-1-3p and miR-16-2-3p strands in both the parental A549 and their radioresistant variant, A549IR cells. The impact of microRNA overexpression on cell viability was evaluated through a clonogenic assay. Additionally, cisplatin sensitivity was measured by calculating the total mass of surviving cells via the sulforhodamine B method. Furthermore, the capacity for cell migration and invasion was investigated using Boyden chambers.
Results: Overexpressing miR-16, miR-16-1-3p, and miR-16-2-3p significantly reduced the ability of A549 and radioresistant A549IR NSCLC cells to survive, clone, migrate, and invade, compared to cells with normal levels of these microRNAs. Moreover, the stable overexpression of these microRNAs markedly enhanced the sensitivity of A549 and A549IR cells to the cytotoxic effects of cisplatin, allowing for a nearly threefold reduction in the concentration needed to achieve 50 % cell death.
Conclusion: An increase in the expression of “passenger” miR-16-1-3p and miR-16-2-3p, as well as the “leader” miR-16, exhibits a robust tumor-suppressive and cisplatin-sensitizing activities in both the radiation-sensitive parental and the radiation-resistant daughter cells in the human NSCLC A549 lineage.
Keywords: non-small cell lung cancer, chemo-radiotherapy, radioresistance, metastasis, invasiveness, miR-16, miR-16-1; miR-16-2
For citation: Malakhov PA, Maximov VV, Pustovalova MV, Smirnova AV, Nofal Z, Saburov V, Osipov AN, Kuzmin DV, Leonov SV. MiR-16-1-3p and miR-16-2-3p Overexpression Confers Tumor Suppressive and Antimetastatic Properties in Radioresistant A549 Non-Small Cell Lung Cancer Cells. Medical Radiology and Radiation Safety. 2025;70(2):27–34. (In Russian). DOI:10.33266/1024-6177-2025-70-2-27-34
References
1. Bray F., Laversanne M., Sung H., et al. Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2024;74;3:229-263. doi:10.3322/caac.21834 PMID: 38572751
2. Zhou T., Zhang L.Y., He J.Z., et al. Review: Mechanisms and Perspective Treatment of Radioresistance in Non-Small Cell Lung Cancer. Front Immunol. 2023;14:1133899. Published 2023 Feb 14. doi:10.3389/fimmu.2023.1133899 PMID: 36865554
3. Jonas S., Izaurralde E. Towards a Molecular Understanding of MicroRNA-Mediated Gene Silencing. Nat Rev Genet. 2015;16;7:421-433. doi:10.1038/nrg3965 PMID: 26077373
4. O’Brien J., Hayder H., Zayed Y., Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne). 2018;9:402. doi:10.3389/fendo.2018.00402 PMID: 30123182
5. Daugaard I., Hansen T.B. Biogenesis and Function of Ago-Associated RNAs. Trends Genet. 2017;33;3:208-219. doi:10.1016/j.tig.2017.01.003 PMID: 28174021
6. Peng Y., Croce C.M. The Role of MicroRNAs in Human Cancer. Signal Transduct Target Ther. 2016;1:15004. doi:10.1038/sigtrans.2015.4 PMID: 29263891
7. Klein U., Lia M., Crespo M., et al. The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and its Deletion Leads to Chronic Lymphocytic Leukemia. Cancer Cell. 2010;17;1:28-40. doi:10.1016/j.ccr.2009.11.019 PMID: 20060366
8. Lovat F., Fassan M., Gasparini P., et al. MiR-15b/16-2 Deletion Promotes B-Cell Malignancies. Proc Natl Acad Sci USA. 2015;112;37:11636-11641. doi:10.1073/pnas.1514954112 PMID: 26324892
9. Lovat F., Fassan M., Sacchi D., et al. Knockout of Both miR-15/16 Loci Induces Acute Myeloid Leukemia. Proc Natl Acad Sci USA. 2018;115;51:13069-13074. doi:10.1073/pnas.1814980115 PMID: 30478046
10. Maximov V.V., Akkawi R., Khawaled S., et al. MiR-16-1-3p and MiR-16-2-3p Possess Strong Tumor Suppressive and Antimetastatic Properties in Osteosarcoma. Int J Cancer. 2019;145;11:3052-3063. doi:10.1002/ijc.32368 PMID: 31018244
11. Hu H., Chen C., Chen F., Sun N. LINC00152 Knockdown Suppresses Tumorigenesis in Non-Small Cell Lung Cancer Via Sponging MiR-16-5p. J Thorac Dis. 2022;14;3:614-624. doi:10.21037/jtd-22-59 PMID: 35399229
12. Biton M., Levin A., Slyper M., et al. Epithelial MicroRNAs Regulate Gut Mucosal Immunity Via Epithelium-T Cell Crosstalk. Nat Immunol. 2011;12;3:239-246. doi:10.1038/ni.1994 PMID: 21278735
13. Chava S., Reynolds C.P., Pathania A.S., et al. MiR-15a-5p, MiR-15b-5p, and MiR-16-5p Inhibit Tumor Progression by Directly Targeting MYCN in Neuroblastoma. Mol Oncol. 2020;14;1:180-196. doi:10.1002/1878-0261.12588 PMID: 31637848
14. Calin G.A., Ferracin M., Cimmino A, et al. A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia [Published Correction Appears in N Engl J Med. 2006 Aug 3;355(5):533]. N Engl J Med. 2005;353;17:1793-1801. doi:10.1056/NEJMoa050995 PMID: 16251535
15. Zhou Y., Huang Y., Dai T., et al. LncRNA TTN-AS1 Intensifies Sorafenib Resistance in Hepatocellular Carcinoma by Sponging MiR-16-5p and Upregulation of Cyclin E1. Biomed Pharmacother. 2021;133:111030. doi:10.1016/j.biopha.2020.111030 PMID: 33378944
16. Zhang X., Zhang J., Liu Q., Zhao Y., Zhang W., Yang H. Circ-CUX1 Accelerates the Progression of Neuroblastoma Via MiR-16-5p/DMRT2 Axis. Neurochem Res. 2020;45;12:2840-2855. doi:10.1007/s11064-020-03132-w PMID: 33000435
17. Wang Z., Hu S., Li X., et al. MiR-16-5p Suppresses Breast Cancer Proliferation by Targeting ANLN. BMC Cancer. 2021;21;1:1188. doi:10.1186/s12885-021-08914-1 PMID: 34743685
18. Du R., Jiang F., Yin Y., et al. Knockdown of lncRNA X Inactive Specific Transcript (XIST) Radiosensitizes Non-Small Cell Lung Cancer (NSCLC) Cells through Regulation of MiR-16-5p/WEE1 G2 Checkpoint Kinase (WEE1) Axis. Int J Immunopathol Pharmacol. 2021;35:2058738420966087. doi:10.1177/2058738420966087 PMID: 33583218
19. Wang Q., Chen Y., Lu H., et al. Quercetin Radiosensitizes Non-Small Cell Lung Cancer Cells through the Regulation of miR-16-5p/WEE1 axis. IUBMB Life. 2020;72;5:1012-1022. doi:10.1002/iub.2242 PMID: 32027086
20. Mohammadi C., Gholamzadeh Khoei S., Fayazi N., Mohammadi Y., Najafi R. MiRNA as Promising Theragnostic Biomarkers for Predicting Radioresistance in Cancer: A Systematic Review and Meta-Analysis. Crit Rev Oncol Hematol. 2021;157:103183. doi:10.1016/j.critrevonc.2020.103183 PMID: 33310279
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The work was supported by Russian Science Foundation (agreement No 23-14-00220).
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.12.2024. Accepted for publication: 25.01.2025.
Medical Radiology and Radiation Safety. 2025. Vol. 70. № 2
DOI:10.33266/1024-6177-2025-70-2-23-26
Yu.A. Zrilova1, A.K. Chigasova1, 2, 3, M.A. Ignatov1, 2, N.Yu. Vorobyеva1, 2,
A.A. Osipov2, V.O. Saburov4, E.I. Kazakov4, S.N. Koryakin4,
Yu.A. Fedotov1, 2, A.Yu. Bushmanov1, A.N. Osipov1, 2
Low Efficiency of DNA Repair in Human Peripheral Blood Lymphocytes Irradiated ex vivo by 14.1 MeV Neutrons
1 A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
2 N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Moscow, Russia
3 Institute of Biochemical Physics of the Russian Academy of Sciences, Moscow, Russia
4 A.F. Tsyb Medical Radiological Research Center – branch of the National Medical Research
Radiological Centre of the Ministry of Health of the Russian Federation, Obninsk
Contact person: A.N. Osipov, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Purpose: To evaluate the efficiency of DNA repair in human peripheral blood lymphocytes irradiated ex vivo by 14.1 MeV neutrons.
Material and methods: The peripheral blood of three physically healthy male donors aged 28–40 years was used for the study. The peripheral blood was collected in K2EDTA vacutainers (Vacuette). All donors gave their consent to conduct this study. Isolation of lymphocytes was performed by centrifugation in a ficoll-verografin density gradient of 1.077 g/cm3 (Histopaque, Sigma-Aldrich) in accordance with the attached instructions. Cell irradiation was performed at the A.F. Tsyb Medical Radiological Research Center on the NG-14 neutron generator (FSUE VNIIA, Russia), which provided neutron fluxes with an energy of 14.1 MeV, and the gamma-therapeutic device “ROKUS-AM” (JSC Ravenstvo, Russia; cobalt-60, dose rate 0.5 Gy/min) at doses of 0.1, 0.25 and 0.5 Gy. To assess the effectiveness of DNA repair, the DNA comet method was used under alkaline conditions. The study was performed immediately after irradiation and after 15 min of cell incubation in complete culture medium at 37 °C. The tail moment and % DNA in the comet tail were used as a criterion for DNA damage. Statistical significance was assessed using analysis of variance (ANOVA).
Results: It was demonstrated that the efficiency of DNA repair in lymphocytes peripheral blood of a person after exposure to 14.1 MeV neutrons is ~ 4–5 times lower than after exposure to cobalt-60 gamma-radiation. The results obtained indicate that in the case of exposure to 14.1 MeV neutron radiation, the contribution of complex, difficult-to-repair DNA damage is much higher than when exposed to gamma radiation, which determines the high relative biological effectiveness of neutron radiation.
Keywords: fast neutrons, lymphocytes, DNA damage, DNA repair, DNA comet assay
For citation: Zrilova YuA, Chigasova AK, Ignatov MA, Vorobyеva NYu, Osipov AA, Saburov VO, Kazakov EI, Koryakin SN, Fedotov YuA, Bushmanov AYu, Osipov AN. Low Efficiency of DNA Repair in Human Peripheral Blood Lymphocytes Irradiated ex vivo by 14.1 MeV Neutrons. Medical Radiology and Radiation Safety. 2025;70(2):23–26. (In Russian). DOI:10.33266/1024-6177-2025-70-2-23-26
References
1. Litvak M.L., Sanin A.B., Mitrofanov I.G., Bakhtin B., Jun I., Martinez-Sierra L.M., et al. Mars Neutron Radiation Environment from HEND/Odyssey and DAN/MSL Observations. Planetary and Space Science. 2020;184. doi: 10.1016/j.pss.2020.104866.
2. Bartlett D.T., Hager L.G., Tanner R.J., Steele J.D. Measurements of the High Energy Neutron Component of Cosmic Radiation Fields in Aircraft Using Etched Track Dosemeters. Radiation Measurements. 2001;33;3:243-53. doi: 10.1016/s1350-4487(00)00098-6.
3. Gordon K., Gulidov I., Fatkhudinov T., Koryakin S., Kaprin A. Fast and Furious: Fast Neutron Therapy in Cancer Treatment. International Journal of Particle Therapy. 2022;9;2:59-69. doi: 10.14338/ijpt-22-00017.
4. Baiocco G., Barbieri S., Babini G., Morini J., Alloni D., Friedland W., et al. The Origin of Neutron Biological Effectiveness as a Function of Energy. Scientific Reports. 2016;6;1. doi: 10.1038/srep34033.
5. Mikerov V., Barmakov Y.N., Bogolubov E., Ryzhkov V. Portable Neutron Generators of Vniia and Their Applications. Proceedings of International Workshop on Fast Neutron Detectors and Applications – PoS(FNDA2006)2007. DOI:10.22323/1.025.0023
6. Osipov A., Arkhangelskaya E., Vinokurov A., Smetaninа N., Zhavoronkov A., Klokov D. DNA Comet Giemsa Staining for Conventional Bright-Field Microscopy. International Journal of Molecular Sciences. 2014;15;4:6086-95. doi: 10.3390/ijms15046086.
7. Osipov A.N., Smetanina N.M., Pustovalova M.V., Arkhangelskaya E., Klokov D. The Formation of DNA Single-Strand Breaks and Alkali-Labile Sites in Human Blood Lymphocytes Exposed to 365-nm UVA Radiation. Free Radical Biology and Medicine. 2014;73:34-40. doi: 10.1016/j.freeradbiomed.2014.04.027.
8. Osipov A.N., Elakov A.L., Puchkov P.V., Pomerantseva M.D., Ramaiya L.K., Klokov D.Y., et al. The Estimation of Molecular and Cytogenetic Effects in Mice Exposed to Chronic Low Dose-Rate Gamma-Radiation. Russian Journal of Genetics. 2002;38;10:1140-1144. doi: 10.1023/a:1020644619267.
9. Osipov A.N., Klokov D.Y., Elakov A.L., Rozanova O.M., Zaichkina S.I., Aptikaeva G.F., et al. Comparison In Vivo Study of Genotoxic Action of High- Versus Very Low Dose-Rate γ-Irradiation. Nonlinearity in Biology, Toxicology, Medicine. 2004 Jul;2;3:223-232 doi: 10.1080/15401420490507521.
10. Grekhova A.K., Gorbacheva L.B., Ivanova N.A., Efimenko I.A., Osipov A.N. Comparative Studies of the Genotoxic Activity of a New Palladium (II) Acidocomplex and Cisplatin in Human Blood Lymphocytes in vitro. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry. 2013;7;3:226-30. doi: 10.1134/s1990750813030050.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The research was carried out within the framework of the state assignment of the Ministry of Science and Higher Education of the Russian Federation (No. 1023112000035-8, code “Cosmos-DNA”).
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.12.2024. Accepted for publication: 25.01.2025.
Medical Radiology and Radiation Safety. 2025. Vol. 70. № 2
DOI:10.33266/1024-6177-2025-70-2-35-39
M.V. Pustovalova1, V.D. Nekrasov1, E.V. Andreev3, 4, I.N. Fadeikina3, 4,
S.V. Leonov1, A.N. Nechaev3, 4, A.N. Osipov1
Synthesized Using β-Cyclodextrin Silver and Gold Nanoparticles
as Radiosensitizers in Breast Cancer Radiotherapy
1 Moscow Institute of Physics and Technology, Dolgoprudny, Russia
2 A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
3 Joint Institute for Nuclear Research, Dubna, Russia
4 Dubna State University, Dubna, Russia
Contact person: A.N. Osipov, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Purpose: 1) Synthesis and characterization of β-cyclodextrin stabilized silver and gold nanoparticles. 2) Evaluation of the effect of the synthesized nanoparticles on the severity of radiobiological effects in irradiated breast cancer (BC) cells.
Material and methods: Gold and silver nanoparticles were synthesized using β-cyclodextrin as a reducing agent and stabilizer. Human BC cell lines MDA-MB-231 (ER-/PR-/ EGFR+/ HER2-) and MCF7 (ER+/ PR+/ EGFR-/ HER2-) were used in the work. The cells were irradiated on a RUB RUST-M1 (Russia) X-ray irradiation facility, equipped with two X-ray emitters, at a dose rate of 0.85 mGy/min, 200 kV voltage, 5.0 mA current, 1.5 mm Al filter. Nanoparticles were added 24 h before irradiation at a concentration of 0.5 mg/l. Cells without nanoparticles were used as a control. To assess radiobiological effects, foci of the DNA damage marker protein (γH2AX) were analyzed 1 and 24 hours after irradiation. Statistical and mathematical data analysis was performed using GraphPad Prism 9.0.2.161 software (GraphPad Software). Statistical significance was assessed using analysis of variance (ANOVA).
Results: Effective radiosensitization of BC cell lines MDA-MB-231 and MCF7 using β-cyclodextrin stabilized gold and silver nanoparticles (AuNPs and AgNPs) was shown. The results obtained indicate the achievement of statistically significant results already at a concentration of 0.5 mg/l, which is at least 20 times less than the concentrations previously used to achieve a significant effect.
Keywords: breast cancer, radiation therapy, radiosensitizers, silver nanoparticles, gold nanoparticles, β-cyclodextrin
For citation: Pustovalova MV, Nekrasov VD, Andreev EV, Fadeikina IN, Leonov SV, Nechaev AN, Osipov AN. Synthesized Using β-Cyclodextrin Silver and Gold Nanoparticles as Radiosensitizers in Breast Cancer Radiotherapy. Medical Radiology and Radiation Safety. 2025;70(2):35–39. (In Russian). DOI:10.33266/1024-6177-2025-70-2-35-39
References
1. Arnold M., Morgan E., Rumgay H., Mafra A., Singh D., Laversanne M., et al. Current and Future Burden of Breast Cancer: Global Statistics for 2020 and 2040. Breast. 2022;66:15-23. doi: 10.1016/j.breast.2022.08.010.
2. Chen Y., Yang J., Fu S., Wu J. Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy. Int J Nanomedicine. 2020;15:9407-30. doi: 10.2147/IJN.S272902.
3. Jackson N., Cecchi D., Beckham W., Chithrani D.B. Application of High-Z Nanoparticles to Enhance Current Radiotherapy Treatment. Molecules. 2024;29;11:24-38. doi: 10.3390/molecules29112438.
4. Khan M.J., Ahmad A., Zamzami M.A., Siddiqui S., Khan M.A. Bidirectional Approach of β-Cyclodextrin-Capped Silver Nanoparticles: Reduction in Toxicity and Enhancement in Antibacterial Activity. Clean Technologies and Environmental Policy. 2023;26;11:3955-64. doi: 10.1007/s10098-023-02618-9.
5. Osipov A., Chigasova A., Yashkina E., Ignatov M., Vorobyeva N., Zyuzikov N., et al. Early and Late Effects of Low-Dose X-ray Exposure in Human Fibroblasts: DNA Repair Foci, Proliferation, Autophagy, and Senescence. International Journal of Molecular Sciences. 2024;25;15:8253. doi: 10.3390/ijms25158253.
6. Osipov A.A., Chigasova A.K., Yashkina E.I., Ignatov M.A., Vorobyеva N.Y., Osipov A.N. Link Between Cellular Senescence and Changes in The Number and Size of Phosphorylated Histone H2ax Foci in Irradiated Human Fibroblasts. Medical Radiology and Radiation Safety. 2024;69;3:13-8. doi: 10.33266/1024-6177-2024-69-3-13-18.
7. Babayan N.S., Guryev D.V., Vorobyeva N.Y., Grigoryan B.A., Tadevosyan G.L., Apresyan L.S., et al. Colony-Forming Ability and Residual Foci of DNA Repair Proteins in Human Lung Fibroblasts Irradiated with Subpicosecond Beams of Accelerated Electrons. Bulletin of Experimental Biology and Medicine. 2021;172;1:22-5. doi: 10.1007/s10517-021-05323-z.
8. Van Oorschot B., Oei A.L., Nuijens A.C., Rodermond H., Hoeben R., Stap J., et al. Decay of Gamma-H2AX Foci Correlates with Potentially Lethal Damage Repair and P53 Status in Human Colorectal Carcinoma Cells. Cell Mol Biol Lett. 2014;19;1:37-51. doi: 10.2478/s11658-013-0113-0.
9. Sorokin M., Kholodenko R., Grekhova A., Suntsova M., Pustovalova M., Vorobyeva N., et al. Acquired Resistance to Tyrosine Kinase Inhibitors May be Linked with the Decreased sensitivity to X-ray Irradiation. Oncotarget. 2017;9;4:5111-24. doi: 10.18632/oncotarget.23700.
10. Olive P.L. Retention of γH2AX Foci as an Indication of Lethal DNA Damage. Radiotherapy and Oncology. 2011;101;1:18-23. doi: 10.1016/j.radonc.2011.05.055.
11. Saito K., McGehee K., Norikane Y. Size-Controlled Synthesis of Cyclodextrin-Capped Gold Nanoparticles for Molecular Recognition Using Surface-Enhanced Raman Scattering. Nanoscale Advances. 2021;3;11:3272-8. doi: 10.1039/d1na00125f.
12. Paramelle D., Sadovoy A., Gorelik S., Free P., Hobley J., Fernig D.G. A Rapid Method to Estimate the Concentration of Citrate Capped Silver Nanoparticles from UV-Visible Light Spectra. The Analyst. 2014;139;19:4855-4861. doi: 10.1039/c4an00978a.
13. Haiss W., Thanh N.T.K., Aveyard J., Fernig D.G. Determination of Size and Concentration of Gold Nanoparticles from UV−Vis Spectra. Analytical Chemistry. 2007;79;11:4215-21. doi: 10.1021/ac0702084.
14. Mirzayans R., Andrais B., Scott A., Wang Y.W., Weiss R.H., Murray D. Spontaneous Gammah2ax Foci in Human Solid Tumor-Derived Cell Lines in Relation to p21WAF1 and WIP1 Expression. International Journal of Molecular Sciences. 2015;16;5:11609-28. doi: 10.3390/ijms160511609.
15. Merkher Y., Kontareva E., Bogdan E., Achkasov K., Maximova K., Grolman J.M., et al. Encapsulation and Adhesion of Nanoparticles as a Potential Biomarker for TNBC Cells Metastatic Propensity. Sci Rep. 2023;13;1:12289. doi: 10.1038/s41598-023-33540-1.
16. Thompson E.A., Graham E., MacNeill C.M., Young M., Donati G., Wailes E.M., et al. Differential Response of MCF7, MDA-MB-231, and MCF 10A Cells to Hyperthermia, Silver Nanoparticles and Silver Nanoparticle-Induced Photothermal Therapy. International Journal of Hyperthermia. 2014;30;5:312-23. doi: 10.3109/02656736.2014.936051.
17. Nosrati H., Salehiabar M., Charmi J., Yaray K., Ghaffarlou M., Balcioglu E., et al. Enhanced in Vivo Radiotherapy of Breast Cancer Using Gadolinium Oxide and Gold Hybrid Nanoparticles. ACS Applied Bio Materials. 2023;6;2:784-92. doi: 10.1021/acsabm.2c00965.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. Radiobiological research was carried out with the support of the Russian Science Foundation (project No. 24-45-20002, https://rscf.ru/project/24-45-20002 /). The synthesis and characterization of nanoparticles were performed within the framework of the state assignment of the Ministry of Science and Higher Education of the Russian Federation (No. 1024011000011-7-1.4.2;3.5.2 Conjugates of boron-containing quantum dots with biovectors for the diagnosis and boron-neutron capture therapy of superficial malignant tumors (FEEM-2024-0011)).
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.12.2024. Accepted for publication: 25.01.2025.